Related Experiment Video
Updated: Nov 27, 2025

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
Published on: November 22, 2024
Progress curve analysis of microtitre plate plasma clotting assays. Assessment of tissue factor levels
Tyrone L R Humphries1, Lambro A Johnson2, Paul P Masci2
1Kidney Disease Research Collaborative, Princess Alexandra Hospital, University of Queensland and Translational Research Institute, Brisbane, Australia.
Abstract:
MTP plasma clotting assays monitor the time course of fibrin formation in re-calcified plasma by absorbance measurements and are increasingly used as alternatives to traditional one-point clot time assays employed in clinical laboratories to detect thrombotic disorders. The parameters derived from these analyses are analogous to thromboelastography viz. time, rate and maximum extent of clot formation. The derived parameters, based on the whole course of the clotting reaction are more robust, informative and quantitative than single-point clot time assays. However, the parameters themselves are usually obtained arbitrarily by crude graphical analysis of subjectively selected points of progress curves. The current work aimed to investigate the sensitivity and reproducibility of an MTP clotting assay and examine its suitability for measuring tissue factor (TF) levels in cell culture medium and patient urine. The results demonstrate that progress curves can be analysed by fitting a logistic equation, derived from a simplified autocatalytic clot formation model. The parameters, maximum amplitude (Fm), rate constant (k), time to half-maximum amplitude (tm) and maximum rate of clot formation (vm), fit a power curve showing limiting effects with increasing TF concentration. Log/log plots of tm and k against TF concentration provide standard curves for assessment of unknowns.
Insights
Microplate-based plasma clotting assays offer a more robust method for detecting thrombotic disorders. Analyzing the full clotting curve with a logistic equation provides quantitative and reproducible measurements of tissue factor levels.
Area of Science:
- Biochemistry
- Hematology
- Clinical Diagnostics
Background:
- Traditional one-point clot time assays have limitations in detecting thrombotic disorders.
- Microplate-based plasma clotting (MTP) assays offer a more comprehensive analysis of fibrin formation.
- Current MTP parameter derivation relies on subjective graphical analysis.
Purpose of the Study:
- To investigate the sensitivity and reproducibility of MTP clotting assays.
- To evaluate MTP assays for measuring tissue factor (TF) levels in biological samples.
- To develop a quantitative method for analyzing MTP clotting progress curves.
Main Methods:
- MTP plasma clotting assays were performed using absorbance measurements.
- Progress curves were analyzed by fitting a logistic equation derived from an autocatalytic model.
- Parameters including maximum amplitude (Fm), rate constant (k), time to half-maximum amplitude (tm), and maximum rate (vm) were calculated.
- TF levels were assessed in cell culture medium and patient urine.
Main Results:
- The logistic equation provided a robust analysis of MTP clotting progress curves.
- Derived parameters (Fm, k, tm, vm) exhibited power-law relationships with TF concentration.
- Increasing TF concentration showed limiting effects on clotting parameters.
- Log/log plots of tm and k against TF concentration yielded standard curves for TF quantification.
Conclusions:
- Fitting a logistic equation to MTP clotting assays enables quantitative and reproducible analysis.
- This method is suitable for measuring TF levels in various biological matrices.
- The developed approach offers an improvement over subjective graphical analysis for clotting assays.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13:08Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012